Antagonization of tumor necrosis factor in snake bite. A new approach for an old threat.

Intensive care medicine ·Vol. 27 ·No. 5 ·2001-05-00 ·Pages 800-2

Abroug F, Nouira S

Abstract

暂无摘要

MeSH Terms

Animals Humans Snake Bites/physiopathology Tumor Necrosis Factor-alpha/antagonists & inhibitors,metabolism Viperidae

Chemicals

Tumor Necrosis Factor-alpha

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Abroug F

Nouira S

References (17)

17 references, click to expand

A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER).
Am J Trop Med Hyg. 1998 Feb;58(2):183-9 PMID: 9580075
Recurrent and persistent coagulopathy following pit viper envenomation.
Arch Intern Med. 1999 Apr 12;159(7):706-10 PMID: 10218750
Time factor in the detection of circulating whole venom and crotoxin and efficacy of antivenom therapy in patients envenomed by Crotalus durissus.
Toxicon. 1997 May;35(5):699-704 PMID: 9203294
Serum interleukin-1beta, interleukin-6, nitric oxide and alpha1-antitrypsin in scorpion envenomed children.
Toxicon. 1998 Dec;36(12):1851-9 PMID: 9839669
First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
Am J Trop Med Hyg. 1997 Mar;56(3):291-300 PMID: 9129531
Venoms, antivenoms and immunotherapy.
Toxicon. 1998 Jun;36(6):823-46 PMID: 9663690
Processing of pro-tumor necrosis factor-alpha by venom metalloproteinases: a hypothesis explaining local tissue damage following snake bite.
Eur J Immunol. 1996 Sep;26(9):2000-5 PMID: 8814237
Serotherapy in scorpion envenomation: a randomised controlled trial.
Lancet. 1999 Sep 11;354(9182):906-9 PMID: 10489950
Early infusion of a purified monospecific F(ab')2 antivenom serum for Bothrops lanceolatus bites in Martinique.
Lancet. 1996 Feb 10;347(8998):406 PMID: 8598738
Antagonization of TNF attenuates systemic hemodynamic manifestations of envenomation in a rat model of Vipera aspis snakebite.
Intensive Care Med. 2001 May;27(5):884-8 PMID: 11430545
Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom.
Ann Emerg Med. 1997 Jul;30(1):49-53 PMID: 9209225
Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its distribution of the venom and its toxin versus slow absorption and distribution of IGG, F(AB')2 and F(AB) of the antivenin.
Toxicon. 1998 Jan;36(1):93-114 PMID: 9604285
Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies.
Ann Emerg Med. 2001 Feb;37(2):189-95 PMID: 11174238
Efficacy, safety, and use of snake antivenoms in the United States.
Ann Emerg Med. 2001 Feb;37(2):181-8 PMID: 11174237
Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations.
Am J Trop Med Hyg. 1986 Nov;35(6):1235-47 PMID: 3538922
Why immunomodulatory therapies have not worked in sepsis.
Intensive Care Med. 1999 Jun;25(6):556-66 PMID: 10416906
Envenoming by viper bites in France: clinical gradation and biological quantification by ELISA.
Toxicon. 1992 May-Jun;30(5-6):599-609 PMID: 1519251

Article Info

Journal

Intensive care medicine

Abbr.

Intensive Care Med

ISSN

0342-4642

DOI

10.1007/s001340100928

Published

2001-05-00

Pages

800-2

Language

English

Region

United States

NLM ID

7704851

Subset

Corrections

CommentOn

PMID: 11430545

External Links

PubMed source DOI: 10.1007/s001340100928 View journal details

Analysis Services

Antagonization of tumor necrosis factor in snake bite. A new approach for an old threat.

Contact

WeChat Official Account